Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis

  • Pratha Sah
    Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06520;
  • Meagan C. Fitzpatrick
    Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06520;
  • Charlotte F. Zimmer
    Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06520;
  • Elaheh Abdollahi
    Agent-Based Modelling Laboratory, York University, Toronto, ON M3J 1P3, Canada;
  • Lyndon Juden-Kelly
    Agent-Based Modelling Laboratory, York University, Toronto, ON M3J 1P3, Canada;
  • Seyed M. Moghadas
    Agent-Based Modelling Laboratory, York University, Toronto, ON M3J 1P3, Canada;
  • Burton H. Singer
    Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610
  • Alison P. Galvani
    Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06520;

説明

<jats:title>Significance</jats:title><jats:p>Asymptomatic infections have been widely reported for COVID-19. However, many studies do not distinguish between the presymptomatic stage and truly asymptomatic infections. We conducted a systematic review and meta-analysis of COVID-19 literature reporting laboratory-confirmed infections to determine the burden of asymptomatic infections and removed index cases from our calculations to avoid conflation. By analyzing over 350 papers, we estimated that more than one-third of infections are truly asymptomatic. We found evidence of greater asymptomaticity in children compared with the elderly, and lower asymptomaticity among cases with comorbidities compared to cases with no underlying medical conditions. Greater asymptomaticity at younger ages suggests that heightened vigilance is needed among these individuals, to prevent spillover into the broader community.</jats:p>

収録刊行物

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ